Lineage Cell Therapeutics, Inc. SEC filings LCTX

Lineage Cell Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 3, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 5, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
10-K Annual report Mar 10, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Apr 29, 2024
10-K Annual report Mar 7, 2024 Dec 31, 2023
ARS Annual report to shareholders Jul 27, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 27, 2023 Dec 31, 2022
10-K Annual report Mar 9, 2023 Dec 31, 2022
10-K Annual report Mar 10, 2022 Dec 31, 2021
10-K Annual report Mar 11, 2021 Dec 31, 2020
10-K/A Amended annual report Apr 28, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2020 Dec 31, 2019
10-K/A Amended annual report May 1, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 30, 2019 Dec 31, 2018
10-K Annual report Mar 14, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 2, 2018 Dec 31, 2017
10-K Annual report Mar 15, 2018 Dec 31, 2017
10-K/A Amended annual report Mar 29, 2017 Dec 31, 2016
10-K Annual report Mar 16, 2017 Dec 31, 2016
10-K/A Amended annual report May 24, 2016 Dec 31, 2015
10-K Annual report Mar 15, 2016 Dec 31, 2015
10-K/A Amended annual report Apr 29, 2015 Dec 31, 2014
10-K Annual report Mar 11, 2015 Dec 31, 2014
10-K/A Amended annual report Apr 29, 2014 Dec 31, 2013
10-K Annual report Mar 17, 2014 Dec 31, 2013
10-K/A Amended annual report Apr 30, 2013 Dec 31, 2012
10-K Annual report Mar 18, 2013 Dec 31, 2012
10-K/A Amended annual report Sep 17, 2012 Dec 31, 2011

Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
LCTX (NYSE)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
Carlsbad, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
876343
Former names
BIOTIME INC (until Aug 8, 2019)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.